Bausch Health Companies (NYSE:BHC) Given New $8.50 Price Target at Royal Bank of Canada
Bausch Health Companies (NYSE:BHC – Get Free Report) had its price objective lowered by analysts at Royal Bank of Canada from $9.00 to $8.50 in a research note issued to investors on Monday,BayStreet.CA reports. The firm presently has a “sector perform” rating on the stock. Royal Bank of Canada’s price objective would indicate a potential […]
Bausch Health Companies (NYSE:BHC – Get Free Report) had its price objective lowered by analysts at Royal Bank of Canada from $9.00 to $8.50 in a research note issued to investors on Monday,BayStreet.CA reports. The firm presently has a “sector perform” rating on the stock. Royal Bank of Canada’s price objective would indicate a potential […]
